Literature DB >> 22015712

Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma.

Jian Zhang1, Lelin Pan, Luyan Chen, Xiaowen Feng, Lin Zhou, Shusen Zheng.   

Abstract

The non-classical human leukocyte antigens (HLA)-E, HLA-G, and HLA-F have been shown to modulate immune responses. We examined whether non-classical HLA polymorphisms are associated with hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). Fifteen Single-nucleotide polymorphisms (SNPs) in these non-classical class I alleles were investigated by ligase detection reaction. A fragment of 650 bp located in the 3' untranslated region of HLA-G was investigated. Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated with altered susceptibility to HBV or HCC, and HLA-F*01:04, HLA-G*01:05N, and HLA-E*01:01 were associated with hepatitis B or hepatitis B complicated with HCC. Six of 16 designated HLA-E, -G, and -F haplotypes were associated with risk of hepatitis B or HCC. Our study provides healthy reference and detailed analyses of non-classical HLA class Ι polymorphisms that provide insight into immune mechanisms involved in susceptibility to hepatitis B and HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015712     DOI: 10.1007/s00251-011-0580-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  39 in total

1.  The polymorphism of human leucocyte antigen-G gene in a healthy population of Iran.

Authors:  R Rahimi; A Zavaran Hosseini; F Yari
Journal:  Int J Immunogenet       Date:  2010-04-30       Impact factor: 1.466

2.  The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes.

Authors:  E C Castelli; C T Mendes-Junior; N H S Deghaide; R S de Albuquerque; Y C N Muniz; R T Simões; E D Carosella; P Moreau; E A Donadi
Journal:  Genes Immun       Date:  2009-10-01       Impact factor: 2.676

3.  HLA-G*0105N allele is associated with augmented risk for HIV infection in white female patients.

Authors:  Ludovica Segat; Eulalia Catamo; Annalisa Fabris; Marcello Morgutti; Pierlanfranco D'Agaro; Cesare Campello; Sergio Crovella
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

4.  Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.

Authors:  Ka-Po Tse; Wen-Hui Su; Kai-Ping Chang; Ngan-Ming Tsang; Chia-Jung Yu; Petrus Tang; Lee-Chu See; Chuen Hsueh; Min-Lee Yang; Sheng-Po Hao; Hong-Yi Li; Ming-Hsi Wang; Li-Ping Liao; Lih-Chyang Chen; Sheue-Rong Lin; Timothy J Jorgensen; Yu-Sun Chang; Yin Yao Shugart
Journal:  Am J Hum Genet       Date:  2009-08-06       Impact factor: 11.025

5.  Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.

Authors:  Jinghe Huang; Patrick Burke; Yue Yang; Katherine Seiss; Jill Beamon; Thai Cung; Ildiko Toth; Florencia Pereyra; Mathias Lichterfeld; Xu G Yu
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

6.  HLA-G polymorphism in a Chinese Han population with recurrent spontaneous abortion.

Authors:  W H Yan; L A Fan; J Q Yang; L D Xu; Y Ge; F J Yao
Journal:  Int J Immunogenet       Date:  2006-02       Impact factor: 1.466

7.  Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself.

Authors:  I Khalil-Daher; B Riteau; C Menier; C Sedlik; P Paul; J Dausset; E D Carosella; N Rouas-Freiss
Journal:  J Reprod Immunol       Date:  1999-07       Impact factor: 4.054

8.  Detection of anti-HLA-F antibodies in sera from cancer patients.

Authors:  Katsuo Noguchi; Manami Isogai; Eri Kuwada; Atsutaka Noguchi; Shigenori Goto; Kohji Egawa
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

9.  Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.

Authors:  Yi-Wen Huang; Chung-Yi Hu; Chi-Lin Chen; Ya-Tang Liao; Chun-Jen Liu; Ming-Yang Lai; Pei-Jer Chen; Sien-Sing Yang; Jui-Ting Hu; Ding-Shinn Chen; Jia-Horng Kao
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

10.  The IMGT/HLA database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

View more
  6 in total

1.  Human leukocyte antigen (HLA-F) polymorphism is associated with chronic HBV infection.

Authors:  Ahmed Baligh Laaribi; Naila Hannachi; Hamza Ben Yahia; Manal Marzouk; Asma Mehri; Manel Belhadj; Salwa Yacoub; Amel Letaief; Hadda-Imene Ouzari; Abdellatif Boudabous; Jalel Boukadida; Roberta Rizzo; Inès Zidi
Journal:  3 Biotech       Date:  2018-01-03       Impact factor: 2.406

2.  Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma.

Authors:  Yongfu Xu; Haixiong Han; Fabiao Zhang; Shangdong Lv; Zhengyu Li; Zheping Fang
Journal:  Oncol Lett       Date:  2014-11-07       Impact factor: 2.967

Review 3.  HLA-E: a novel player for histocompatibility.

Authors:  Thomas Kraemer; Rainer Blasczyk; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-10-20       Impact factor: 4.818

Review 4.  Clinical Relevance of HLA Gene Variants in HBV Infection.

Authors:  Li Wang; Zhi-Qiang Zou; Kai Wang
Journal:  J Immunol Res       Date:  2016-05-08       Impact factor: 4.818

Review 5.  Dimorphism of HLA-E and its Disease Association.

Authors:  Leonid Kanevskiy; Sofya Erokhina; Polina Kobyzeva; Maria Streltsova; Alexander Sapozhnikov; Elena Kovalenko
Journal:  Int J Mol Sci       Date:  2019-11-04       Impact factor: 5.923

6.  Human Leukocyte Antigen-E Alleles are Associated with Hepatitis C Virus, Torque Teno Virus, and Toxoplasma Co-infections but are not Associated with Hepatitis B Virus, Hepatitis D Virus, and GB Virus C Co-infections in Human Immunodeficiency Virus Patients.

Authors:  Afiono Agung Prasetyo; Ruben Dharmawan; Irvan Raharjo
Journal:  J Glob Infect Dis       Date:  2016 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.